Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-α as second-line treatment of advanced transitional cell cancer of the urothelial tract

P. H.M. De Mulder, C. Theodore, A. Sella, O. Koriakine, C. N. Sternberg, L. Collette, C. De Balincourt

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-α as second-line treatment of advanced transitional cell cancer of the urothelial tract'. Together they form a unique fingerprint.

Medicine & Life Sciences